Results 101 to 110 of about 360,530 (300)

Carbon Ion Beam Reirradiation in Recurrent High-Grade Glioma

Cancer Management and Research, 2020
Fabian Eberle, 1–4 Stefan Lautenschläger, 4 Rita Engenhart-Cabillic, 1, 3, 4 Alexandra D Jensen, 5 Barbara Carl, 6 Marco Stein, 7 Jürgen Debus, 1–3, 8–11 Henrik Hauswald 1–4, 8, 10, 11 1Department of Radiation Oncology,
Eberle F, Lautenschläger S, Engenhart-Cabillic R, Jensen AD, Carl B, Stein M, Debus J, Hauswald H   +7 more
doaj  

Readability of Online Patient Education Materials in Radiation Oncology – Are We Improving? [PDF]

, 2019
Michael K. Rooney, Sean Sachdev, Jaemin Byun, Reshma Jagsi, Daniel W. Golden   +4 more
openalex   +1 more source

Long-term Outcomes of Chemoradiation for Muscle-invasive Bladder Cancer in Noncystectomy Candidates. Final Results of NRG Oncology RTOG 0524—A Phase 1/2 Trial of Paclitaxel + Trastuzumab with Daily Radiation or Paclitaxel Alone with Daily Irradiation [PDF]

, 2023
Douglas M. Dahl, Theodore Karrison, M. Dror Michaelson, Huong Pham, Chin‐Lee Wu, Gregory P. Swanson, William U. Shipley, Jacqueline Vuky, R. Jeffrey Lee, Anthony L. Zietman, Luís Souhami, Brian K. Chang, Richard L. Deming, John Ellerton, Howard M. Sandler, Joseph P. Rodgers, Felix Y. Feng, Jason A. Efstathiou   +17 more
openalex   +1 more source

AI‐Powered Framework for Evaluating Drug Efficacy for Three‐Dimensional In Vitro Cancer Models in Robot‐Assisted Production

Advanced Robotics Research, EarlyView.
An AI‐powered, robot‐assisted framework automatically produces, images, and analyzes 3D tumor spheroids to evaluate drug efficacy. Integrated modules handle spheroid formation, live/dead staining, brightfield imaging, and automated image analysis, including spheroid segmentation, viability and metrics to assess the drug treatment efficacy. The workflow
Dalia Mahdy, Jesus Nieves, Lukas Königer, Matthias Peindl, Fabio Erhard, Marc Möllmann, Anke Klingner, Markus Münig, Bibin Babu, Thomas Schwarz, Marco Metzger, Gudrun Dandekar, Maximiliane Wußmann, Jan Hansmann   +13 more
wiley   +1 more source

Diagnosis and management of brain metastases: an updated review from a radiation oncology perspective

, 2019
Enrique Gutiérrez, Irving Sánchez, Baderrama-Ibarra Ricardo, Fuentes-Lara Jesus, Rios-Martinez Alan, Vazquez Aldana Arroyo Inigo, Bayardo-Lopez Luis, Hernandez Chavez Allan, Ana Graciela Puebla‐Mora, Nader-Roa Liliana, Espiritu-Rodriguez Roque   +10 more
openalex   +2 more sources

Evaluating the Impact of the Proposed Radiation Oncology Model: How Pressure to Lower Costs May Result in Reduced Access to Care [PDF]

, 2020
M. Dziemianowicz, Jay Burmeister, M.M. Dominello   +2 more
openalex   +1 more source

Challenges and Solutions for Establishing Robust Diversity, Equity, and Inclusion Efforts in US Academic Radiation Oncology Departments [PDF]

, 2023
Sara Beltrán Ponce, Idalid Franco, Kelly C. Paradis, Malcolm D. Mattes   +3 more
openalex   +1 more source

Interactions of Antibody Drug Conjugate Anti‐Tubulin and Topoisomerase I Inhibitor Payloads with Radiotherapy to Potentiate Immunotherapy

Advanced Science, EarlyView.
Antibody drug conjugates deliver their cytotoxic anti‐tubulin or topoisomerase I inhibitor payloads to tumors through cancer cell receptor targeting. The released drug payloads induce cellular changes that interact with radiotherapy resulting in radiosensitization that improves cancer cell kill and stimulates anti‐tumor immune responses.
Jacqueline Lesperance, Bryan S. Yung, Michael M. Allevato, Marcus M Cheng, Maria F. Camargo, Robert Saddawi‐Konefka, Kanika Dhawan, Ashwyn K. Sharma, Mahsa Mortaja, Sophie Bice, Daniel J. Scanderbeg, Diego Alvarado, Jyoti Mayadev, Ramez N. Eskander, Stephen R. Adams, Pippa F. Cosper, J. Silvio Gutkind, Sunil J. Advani   +17 more
wiley   +1 more source

Radiation therapy compared with chemotherapy for consolidation of chemotherapy-induced remission of advanced Hodgkin lymphoma: a study by the Eastern Co-operative Oncology Group (E1476) with >20 years follow-up

, 2009
Peter H. Wiernik, Fangxin Hong, John H. Glick, John M. Bennett   +3 more
openalex   +2 more sources

Mitochondrial Calcium Uniporter Drives Chemoresistance in Pancreatic Cancer via Glutathione‐Mediated Stemness Maintenance

Advanced Science, EarlyView.
PDAC has a poor prognosis due to chemoresistance. We revealed that MCU upregulation is associated with chemoresistance and stemness in PDAC. MCU‐mediated Ca2+ influx induced ER stress, activating the PERK‐ATF4/NRF2 axis to enhance PSAT1/SLC711 expression and glutathione synthesis, reducing ROS and maintaining stemness.
Zekun Li, Chenyang Meng, Guangcong Shen, Yueying Shan, Junjin Wang, Diliyaer Abudukeremu, Rui Zhao, Bo Ni, Chao Xu, Xiaofan Guo, Jun Yu, Kaiyuan Wang, Shengyu Yang, YunZhan Li, Yongjie Xie, Tianxing Zhou, Jihui Hao, Xiuchao Wang   +17 more
wiley   +1 more source